About Essential Inventions



Essential Inventions, Inc. is a non-profit corporation organized under the laws of the District of Columbia in January 2004. The Corporationss Articles state that it was organized to "promote the creation and distribution of essential inventions and other works that support public health, nutrition, learning, and access to information and cultural life."

Board of Directors
  • James Love, Chairman
  • Terry Gardiner
  • Joy Spencer
  • Robert Weissman
  • Chief Executive Officer
  • Michelle Childs
  • Advisory Board
  • Peter Arno, PhD
    Health care economist
    Albert Einstein College of Medicine of Yeshiva University

  • Lynda Dee
    Attorney at Law
    AIDS Treatment Activist Coalition
    Co-chair, Drug Development Committee

  • John Erickson, PhD
    President, Sequoia Pharmaceuticals

  • William Haddad
    Chairman/CEO Biogenerics, Inc.

  • Dr Tim Hubbard
    Head of Human Genome Analysis,
    Wellcome Trust Sanger Institute

  • David Hoos MD
    Assistant Professor, Clinical Epidemiology
    Columbia University

  • Jennifer Jenkins
    Lecturing Fellow
    Duke Law School

  • John Merz JD, PhD
    Assistant Professor, Department of Medical Ethics,
    University of Pennsylvania

  • Hee-Seob Nam
    Partner, Horizon Law Group, Korea Member, Korean Patent Bar, Korea Industrial Property Law Association, Asian Patent Attorneys Association, and International Association for the Protection of Intellectual Property.

  • James Orbinski
    Research Scientist, Associate Professor
    St. Michael's Hospital, Toronto

  • Joshua Sarnoff
    Professor and Assistant Director, Glushko Samuelson Intellectual Property Law Clinic
    Washington College of Law, American University

  • Sidney J Socolar, PhD
    Co-Chair, Committee on Public Policy
    Public Health Association, NYC

  • Jonathan Soverow,
    AIDS Regional Action Coordinator
    The American Medical Student Association (AMSA)
  • Staff
  • Michelle Childs, CEO
  • Robert Weissman, Counsel
  • Joy Spencer, Licensing Agent
  • Gaelle Krikorian, Consultant, Access to HIV Medicines